Patent · US Active

PCV/mycoplasma hyopneumoniae/lawsonia intracellularis combination vaccine

US10206993B2 · kind B2 · utility

4Cited by

51References

22Claims

0Family size

Assignee

ZOETIS SERVICES LLC · US

Inventors

Gregory Paul Nitzel · Paw Paw, US
Jeffrey E. Galvin · Lincoln, US
John Keith Garrett · North Wilkesboro, US
James R. Kulawik, II · Lincoln, US
Tracy L. Ricker · Portage, US
Megan Marie Smutzer · Kalamazoo, US

Key dates

Filing date	Apr 6, 2017
Grant date	Feb 19, 2019
Priority date	—
Expiry date	Apr 6, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/10034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides a multivalent immunogenic composition including a soluble portion of a Mycoplasma hyopneumoniae (M.hyo) whole cell preparation; a porcine circovirus type 2 (PCV2) antigen; and a Lawsonia intracellularis antigen, wherein the soluble portion of the M.hyo preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.